Introduction to Drug Design & Combinatorial Chemistry
The final unit shifts from individual drug chemistry to the SCIENCE of discovering new drugs rationally. It covers classical drug design approaches, Quantitative Structure-Activity Relationship (QSAR) — the mathematical framework that correlates a drug’s physicochemical properties with its biological activity using parameters like log P, Hammett σ, and Taft Es. The Hansch analysis equation is the centerpiece calculation. The unit concludes with modern computational techniques (pharmacophore modeling, molecular docking) and Combinatorial Chemistry — the high-throughput synthesis strategy that generates massive compound libraries.
Syllabus & Topics
- 1Drug Design – Overview: Drug design = rational modification of molecular structure to optimize biological activity, selectivity, pharmacokinetics, and safety. Two broad approaches: (1) Ligand-based (when receptor structure unknown — use SAR from known active compounds). (2) Structure-based/Receptor-based (when receptor 3D structure known — design molecules to fit the binding site). Classical approaches: Random screening → Lead identification → Lead optimization → QSAR → Computational methods.
- 2Classical Approaches in Drug Design: (1) Random screening: test large numbers of compounds against target (low hit rate but discovered many drugs). (2) Molecular modification: modify a known active drug (me-too drugs) — bioisosteric replacement, homologation, ring variation. (3) Mechanism-based: design inhibitors based on known enzyme mechanisms (transition-state analogs, suicide substrates). (4) Serendipity: accidental discovery (Penicillin, Sildenafil). (5) Pharmacophore-based: identify the essential 3D arrangement of features required for activity.
- 3Bioisosteric Replacement: Replacing a functional group with another having similar size, shape, electronic properties, and biological activity. Classical bioisosteres: –CH₃ ↔ –F (similar size), –OH ↔ –NH₂, –COOH ↔ –SO₂NH₂ (tetrazole), –S– ↔ –CH₂–, –O– ↔ –NH–. Non-classical bioisosteres: –COOH ↔ tetrazole (Losartan), phenyl ↔ thienyl. Purpose: improve potency, selectivity, metabolic stability, oral absorption, or reduce toxicity.
- 4QSAR – Concept: Quantitative Structure-Activity Relationship — biological activity is a function of physicochemical properties. If you can measure these properties and correlate them mathematically with activity, you can PREDICT activity for new compounds before synthesizing them. Three key physicochemical parameters: (1) Hydrophobicity (lipophilicity): log P, π. (2) Electronic effects: Hammett σ. (3) Steric effects: Taft Es. QSAR equation: log(1/C) = f(log P, σ, Es).
- 5Partition Coefficient (log P) & Hansch π: log P = log([Drug in octanol]/[Drug in water]) — measures lipophilicity. Higher log P → more lipophilic → better membrane penetration but poorer water solubility. Optimal log P exists for each pharmacological category (parabolic relationship). Hansch substituent lipophilicity constant: π(X) = log P(X-substituted) − log P(unsubstituted). π > 0 → substituent is lipophilic (–CH₃, –Cl, –Br). π < 0 → hydrophilic (–OH, –NH₂, –COOH).
- 6Hammett’s Electronic Parameter (σ): Measures the electron-withdrawing or electron-donating effect of a substituent on an aromatic ring. Defined from ionization of substituted benzoic acids: σ(X) = log Ka(X) − log Ka(H). σ > 0 → electron-withdrawing group (–NO₂, –CN, –CF₃, halogens) → increases acidity. σ < 0 → electron-donating group (–CH₃, –OH, –OCH₃, –NH₂) → decreases acidity. σ(para) and σ(meta) are tabulated separately (different electronic pathways).
- 7Taft’s Steric Parameter (Es): Measures the steric (size/bulkiness) effect of a substituent. Defined from the rate of acid-catalyzed hydrolysis of substituted esters: Es = log(kₓ/k_H). Es is always NEGATIVE (larger substituent → slower hydrolysis → more negative Es). H (reference) = 0, CH₃ = −1.24, C₂H₅ = −1.31, i-Pr = −1.71, t-Bu = −2.78. Bulky substituents may block access to binding site or cause unfavorable steric clashes with receptor.
- 8Hansch Analysis (Free-Wilson Approach Alternative): The Hansch equation is the most widely used QSAR model: log(1/C) = a·π + b·σ + c·Es + d (linear model) or log(1/C) = a·(log P) − b·(log P)² + c·σ + d·Es + e (parabolic model for log P). Where: C = minimum concentration for standard biological response (lower C = more potent), constants a, b, c, d, e determined by multiple regression analysis. The equation allows prediction of activity for new analogs from their physicochemical parameters. Optimal log P (log P₀) from parabolic fit = a/2b.
- 9Solving a Hansch Problem: Given: log(1/C) values for a series of compounds + their π, σ, Es values. Step 1: Tabulate all data. Step 2: Perform multiple linear regression (usually given in exam as the derived equation). Step 3: Substitute π, σ, Es for a proposed new compound into the equation → predict log(1/C). Step 4: Determine optimal substituent profile. Example: If equation is log(1/C) = 1.2π − 0.8σ + 0.5Es + 3.0, a proposed substituent with π=0.5, σ=−0.3, Es=−0.5 gives: log(1/C) = 1.2(0.5) − 0.8(−0.3) + 0.5(−0.5) + 3.0 = 3.59.
- 10Pharmacophore Modeling: A pharmacophore is the 3D arrangement of physicochemical features (hydrogen bond donors/acceptors, hydrophobic centers, aromatic rings, positive/negative charges) that are ESSENTIAL for a molecule to interact with a specific biological target. Identified by superimposing multiple active compounds → finding the common spatial pattern. Software: Catalyst, Phase, LigandScout. Does NOT represent a real molecule — it is an abstract model of the minimum features needed for activity.
- 11Molecular Docking: Computational technique that predicts how a small molecule (ligand) binds into the binding site of a target protein (receptor/enzyme). Process: (1) 3D structure of protein obtained (X-ray crystallography, cryo-EM, homology modeling). (2) Ligand placed in binding site in various orientations. (3) Scoring function ranks poses by binding energy (more negative = better). (4) Best poses analyzed for key interactions (H-bonds, hydrophobic contacts, π-π stacking). Software: AutoDock, Glide, GOLD. Used for virtual screening of large compound libraries → shortlisting candidates for synthesis.
- 12Combinatorial Chemistry – Concept: Traditional chemistry: synthesize one compound at a time → slow. Combinatorial chemistry: systematically generate LARGE LIBRARIES of diverse compounds in a single process by combining sets of building blocks. If you have 10 amines and 10 acids, you can generate 100 amide products in one combinatorial experiment. Purpose: rapid generation of compound libraries for high-throughput screening (HTS) to identify hits/leads.
- 13Solid-Phase Synthesis (Merrifield Method): Building blocks are attached to an insoluble polymer bead (resin — e.g., Wang resin, Rink amide resin) via a cleavable linker. Reactions performed on the bead → excess reagents/byproducts washed away (simple filtration, no chromatography needed). After all coupling steps, the final product is cleaved from the resin. Advantages: easy purification (wash), excess reagents drive reactions to completion, automation possible. Split-and-mix technique: divides beads into portions, couples different building blocks, remixes → exponential library growth.
- 14Solution-Phase Synthesis: Reactions performed in solution (traditional flask chemistry). All purification by extraction, chromatography, crystallization. Advantages: easier reaction monitoring (TLC, NMR), no linker chemistry needed, can use any reaction conditions. Disadvantages: purification is tedious for large libraries. Parallel synthesis: multiple reactions run simultaneously in multi-well plates → moderate-sized focused libraries. Better for optimization around a specific lead.
Learning Objectives
Exam Prep Questions
Q1. What Is the Hansch Equation and How Is It Used?
The Hansch equation is used in Quantitative Structure Activity Relationship studies to correlate biological activity with physicochemical properties of molecules. The equation is:
log(1/C) = a·π + b·σ + c·Es + d
Where:
C = minimum effective concentration of the drug
π = lipophilicity parameter
σ = electronic substituent constant
Es = steric substituent constant
a, b, c, d = regression coefficients determined statistically from experimental data
By calculating π, σ, and Es values for new analogs and substituting them into the equation, scientists can predict biological activity before synthesis. This helps prioritize which compounds should be synthesized and tested during drug design.
Q2. What Is the Difference Between Log P and π?
The Partition coefficient logP represents the absolute lipophilicity of an entire molecule, defined as the logarithm of its partition coefficient between octanol and water.
The Hansch substituent constant (π) measures the relative contribution of a substituent to lipophilicity. It is calculated as:
π(X) = logP(substituted compound) − logP(parent compound)
Thus:
log P describes the lipophilicity of the whole molecule.
π describes how a specific substituent changes that lipophilicity.
For example, if benzene has log P = 2.13 and chlorobenzene has log P = 2.84, then π(Cl) = 0.71, showing that chlorine increases lipophilicity.
Q3. What Is a Pharmacophore?
A Pharmacophore is an abstract three-dimensional model that represents the spatial arrangement of features required for a molecule to interact with a specific biological target and produce a biological response.
Typical pharmacophoric features include:
Hydrogen bond donors
Hydrogen bond acceptors
Hydrophobic centers
Aromatic rings
Positive or negative ionizable groups
The pharmacophore model is derived by overlaying the 3D structures of several active molecules and identifying the common features necessary for binding to a biological target such as a receptor or enzyme.
Q4. What Is the Advantage of Solid-Phase Over Solution-Phase Synthesis?
Solid phase synthesis offers several advantages compared with Solution phase synthesis:
Advantages of solid-phase synthesis:
Purification is simple because products remain attached to solid beads and impurities can be washed away.
Excess reagents can be used to drive reactions to completion.
Easily automated using robotic synthesizers.
Split-and-mix techniques allow rapid generation of large combinatorial libraries.
However, it requires specialized linker chemistry and reactions that are compatible with solid supports. Solution-phase synthesis allows easier reaction monitoring using techniques like TLC or NMR but requires purification after each step.
Q5. What Is a Bioisostere?
A Bioisostere is an atom or group that can replace another atom or group in a molecule while maintaining similar biological activity.
Bioisosteric replacement is widely used in drug design to improve pharmacokinetics, reduce toxicity, or enhance potency while maintaining activity at the biological target.
A classic example occurs in Losartan, where a tetrazole ring replaces a carboxylic acid group. The tetrazole ring has similar acidity and size but improves metabolic stability and oral bioavailability while maintaining binding to the Angiotensin II type 1 receptor.